4.8 Editorial Material

MTOR regulates autophagic flux in the glomerulus

Journal

AUTOPHAGY
Volume 8, Issue 4, Pages 696-698

Publisher

LANDES BIOSCIENCE
DOI: 10.4161/auto.19386

Keywords

MTOR; autophagy; podocyte; proteinuria; rapamycin; autolysosomal reformation

Categories

Ask authors/readers for more resources

Sirolimus (rapamycin), an inhibitor of the mechanistic target of rapamycin (MTOR), was originally proposed as an immunosuppressant to prevent rejection of solid organ transplants. There were expectations that MTOR inhibitors would replace nephrotoxic calcineurin inhibitors (CNIs). Despite its potential advantages, evidence that sirolimus causes de novo or worsening proteinuria is unequivocal. Given the well-recognized proteinuric effect of MTOR inhibitors, we were interested in understanding its role in maintaining the glomerular filtration barrier. To investigate this in vivo, we developed a mouse model with a podocyte selective deletion of the Mtor gene (Mtor pod-KO).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Geriatrics & Gerontology

Management guideline for Werner syndrome 2020. 6. Skin ulcers associated with Werner syndrome: Prevention and non-surgical and surgical treatment

Yoshitaka Kubota, Minoru Takemoto, Toshibumi Taniguchi, Sei-ichiro Motegi, Akira Taniguchi, Hironori Nakagami, Yoshiro Maezawa, Masaya Koshizaka, Hisaya Kato, Seijiro Mori, Kazuhisa Tsukamoto, Masafumi Kuzuya, Koutaro Yokote

Summary: Skin ulcers in patients with Werner syndrome are often found at the distal one-third of the lower legs, with calluses being a common issue. Addressing calluses for treatment or prevention of ulcers is crucial for improving the quality of life for these patients.

GERIATRICS & GERONTOLOGY INTERNATIONAL (2021)

Article Geriatrics & Gerontology

Management guideline for Werner syndrome 2020 1. Dyslipidemia and fatty liver associated with Werner syndrome

Kazuhisa Tsukamoto, Minoru Takemoto, Yoshitaka Kubota, Toshibumi Taniguchi, Sei-ichiro Motegi, Akira Taniguchi, Hironori Nakagami, Yoshiro Maezawa, Masaya Koshizaka, Hisaya Kato, Seijiro Mori, Masafumi Kuzuya, Koutaro Yokote

Summary: The characteristics of dyslipidemia and fatty liver in patients with Werner syndrome in Japan were examined by searching case reports. Treatment methods were not well described in the reports, so detailed data from 12 cases were analyzed at Chiba University.

GERIATRICS & GERONTOLOGY INTERNATIONAL (2021)

Article Geriatrics & Gerontology

Management guideline for Werner syndrome 2020 8. Calcification in tendons associated with Werner syndrome

Akira Taniguchi, Yasuhito Tanaka, Minoru Takemoto, Yoshitaka Kubota, Toshibumi Taniguchi, Sei-ichiro Motegi, Hironori Nakagami, Yoshiro Maezawa, Masaya Koshizaka, Hisaya Kato, Kazuhisa Tsukamoto, Seijiro Mori, Masafumi Kuzuya, Koutaro Yokote

Summary: The study clarified the diagnostic value of calcification in the Achilles tendon for Werner syndrome by comparing patients with and without the syndrome. The results showed a significantly higher frequency of Achilles tendon calcification in patients with Werner syndrome, suggesting it could be included in diagnostic criteria for the syndrome.

GERIATRICS & GERONTOLOGY INTERNATIONAL (2021)

Article Endocrinology & Metabolism

Assessing Patient Satisfaction Following Sodium Glucose Co-Transporter 2 Inhibitor Treatment for Type 1 Diabetes Mellitus: A Prospective Study in Japan

Ryoichi Ishibashi, Yusuke Baba, Kyoka Kakinuma, Atsushi Takasaki, Chihiro Hiraga, Tomomi Harama, Tetsuya Yamamoto, Susumu Nakamura, Masaya Koshizaka, Yoshiro Maezawa, Daigaku Uchida, Fumitaka Okajima

Summary: The study found that the use of SGLT2 inhibitors in patients with type 1 diabetes can improve treatment satisfaction and may improve glycemic variability, while caution should be taken to avoid severe side effects.

DIABETES THERAPY (2021)

Article Genetics & Heredity

A novel podocyte protein, R3h domain containing-like, inhibits TGF-β-induced p38 MAPK and regulates the structure of podocytes and glomerular basement membrane

Takahiro Ishikawa, Minoru Takemoto, Yoshihiro Akimoto, Aki Takada-Watanabe, Kunimasa Yan, Kenichi Sakamoto, Yoshiro Maezawa, Miyuki Suguro, Liqun He, Karl Tryggvason, Christer Betsholtz, Koutaro Yokote

Summary: A novel podocyte-expressed protein R3h domain containing-like (R3hdml) was identified, which inhibits podocyte apoptosis by suppressing TGF-beta-mediated p38 MAPK signaling. Overexpression of R3hdml ameliorated albuminuria in STZ-induced diabetes mice, suggesting it may be a potential therapeutic strategy for diabetic nephropathy.

JOURNAL OF MOLECULAR MEDICINE-JMM (2021)

Article Endocrinology & Metabolism

Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Type 1 Diabetes Mellitus on Body Composition and Glucose Variabilities: Single-Arm, Exploratory Trial

Yusuke Baba, Ryoichi Ishibashi, Atsushi Takasaki, Chiho Ito, Atsuko Watanabe, Megumi Tokita, Miwako Meguro, Tomomi Harama, Kiichi Hirayama, Tetsuya Yamamoto, Susumu Nakamura, Masaya Koshizaka, Yoshiro Maezawa, Daigaku Uchida, Fumitaka Okajima

Summary: SGLT2 inhibitors have beneficial effects on reducing fat mass and glycemic variabilities in patients with type 1 diabetes mellitus, but concerns exist regarding the reduction of skeletal muscle, especially in lean patients.

DIABETES THERAPY (2021)

Article Endocrinology & Metabolism

Central administration of sodium-glucose cotransporter-2 inhibitors increases food intake involving adenosine monophosphate-activated protein kinase phosphorylation in the lateral hypothalamus in healthy rats

Kenji Takeda, Hiraku Ono, Ko Ishikawa, Tomohiro Ohno, Jin Kumagai, Hidetoshi Ochiai, Ai Matumoto, Hidetaka Yokoh, Yoshiro Maezawa, Koutaro Yokote

Summary: The study demonstrates that SGLT2 inhibitors in the CNS can increase food intake, potentially regulating it through AMPK phosphorylation in the lateral hypothalamic area.

BMJ OPEN DIABETES RESEARCH & CARE (2021)

Article Multidisciplinary Sciences

Cellular crosstalk regulates the aqueous humor outflow pathway and provides new targets for glaucoma therapies

Benjamin R. Thomson, Pan Liu, Tuncer Onay, Jing Du, Stuart W. Tompson, Sol Misener, Raj R. Purohit, Terri L. Young, Jing Jin, Susan E. Quaggin

Summary: Primary congenital glaucoma (PCG) is a severe disease with increased intraocular pressure, and variants in ANGPT1 or SVEP1 have been identified as risk alleles. Deletion of these genes induces glaucoma in mice, and activation of ANGPT1-TEK signaling ameliorates disease progression in mouse models.

NATURE COMMUNICATIONS (2021)

Article Hematology

Endothelial Tyrosine Kinase Tie1 Is Required for Normal Schlemm's Canal Development-Brief Report

Jing Du, Benjamin R. Thomson, Tuncer Onay, Susan E. Quaggin

Summary: Studies have shown that Tie1 plays a crucial role in the development and function of Schlemm's canal. Loss of Tie1 leads to hypomorphic Schlemm's canal and elevated intraocular pressure. Therefore, Tie1 may be a novel target for future glaucoma therapies.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2022)

Article Hematology

A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency

Hisaya Kato, Yoshiro Maezawa, Dai Nishijima, Eisuke Iwamoto, June Takeda, Takashi Kanamori, Masaya Yamaga, Tatsuzo Mishina, Yusuke Takeda, Shintaro Izumi, Yutaro Hino, Hiroyuki Nishi, Jun Ishiko, Masahiro Takeuchi, Hiyori Kaneko, Masaya Koshizaka, Naoya Mimura, Masafumi Kuzuya, Emiko Sakaida, Minoru Takemoto, Yuichi Shiraishi, Satoru Miyano, Seishi Ogawa, Atsushi Iwama, Masashi Sanada, Koutaro Yokote

Summary: Werner syndrome (WS) is associated with myelodysplastic syndrome/acute myeloid leukemia (MDS/AML), and patients are prone to TP53 gene mutations and chromosomal abnormalities involving TP53, rather than other common mutations related to MDS/AML. These mutations may be related to WRN gene mutations and p53 insufficiency, leading to complex chromosomal abnormalities and the development of myeloid malignancies.

EXPERIMENTAL HEMATOLOGY (2022)

Article Multidisciplinary Sciences

Primary cilia TRP channel regulates hippocampal excitability

Thuy N. Vien, My C. Ta, Louise F. Kimura, Tuncer Onay, Paul G. DeCaen

Summary: In this study, the researchers found that PKD2L1 localizes and functions as a Ca2+ channel in the primary cilia of hippocampal neurons. Loss of PKD2L1 expression disrupts primary ciliary maturation, weakens neuronal high-frequency excitability, and leads to seizure susceptibility and autism spectrum disorder-like behavior in mice. The disproportionate impairment of interneuron excitability suggests that circuit disinhibition underlies the neurophenotypic features of these mice. These findings identify PKD2L1 channels as regulators of hippocampal excitability and the neuronal primary cilia as organelle mediators of brain electrical signaling.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Endocrinology & Metabolism

Updates on dyslipidemia in patients with diabetes

Shintaro Ide, Yoshiro Maezawa, Koutaro Yokote

JOURNAL OF DIABETES INVESTIGATION (2023)

Article Endocrinology & Metabolism

Weight loss improves inflammation by T helper 17 cells in an obese patient with psoriasis at high risk for cardiovascular events

Yoshiro Maezawa, Yusuke Endo, Satomi Kono, Tomohiro Ohno, Yuumi Nakamura, Naoya Teramoto, Ayano Yamaguchi, Kazuto Aono, Takuya Minamizuka, Hisaya Kato, Takahiro Ishikawa, Masaya Koshizaka, Minoru Takemoto, Toshinori Nakayama, Koutaro Yokote

Summary: Psoriasis, a chronic inflammatory skin disease, is associated with obesity and myocardial infarction. Obesity-induced changes in lipid metabolism promote the differentiation of T helper 17 (Th17) cells, leading to chronic inflammation. This study found that weight loss through diet and exercise decreased Th17 cells and improved psoriasis in an obese patient with type 2 diabetes. This supports the hypothesis that obesity increases Th17 cells and chronic inflammation, contributing to psoriasis and atherosclerosis.

JOURNAL OF DIABETES INVESTIGATION (2023)

Article Physiology

Formation of the glomerular microvasculature is regulated by VEGFR-3

Michael D. Donnan, Dilip K. Deb, Tuncer Onay, Rizaldy P. Scott, Eric Ni, Yalu Zhou, Susan E. Quaggin

Summary: Targeting VEGFR-3 in kidney lymphatics has been proposed as a method to treat kidney disease. However, expression of VEGFR-3 is not lymphatic-specific. We demonstrated developmental expression of VEGFR-3 in glomerular endothelial cells, with loss of Vegfr-3 leading to malformation of glomerular capillary loops. Furthermore, we showed that VEGFR-3 attenuates VEGFR-2 activity in glomerular endothelial cells independent of paracrine VEGF-C signaling. Together, these data provide valuable information for therapeutic development targeting these pathways.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2023)

Article Urology & Nephrology

Stromal Transcription Factor 21 Regulates Development of the Renal Stroma via Interaction with Wnt/beta-Catenin Signaling

Gal Finer, Yoshiro Maezawa, Shintaro Ide, Tuncer Onay, Tomokazu Souma, Rizaldy Scott, Xiaoyan Liang, Xiangmin Zhao, Gaurav Gadhvi, Deborah R. Winter, Susan E. Quaggin, Tomoko Hayashida

Summary: Kidney formation requires interactions between various cell types, with interstitial progenitor cells playing a crucial role. Tcf21 in Foxd1+ interstitial progenitors is shown to regulate stromal formation and differentiation through interaction with beta-catenin. The absence of Tcf21 leads to decreased stromal cell proliferation and defective differentiation of interstitial cells in the kidney.

KIDNEY360 (2022)

No Data Available